Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing
On January 21, 2021, CorMedix Inc. (the "Company") announced that it has been
approved for listing on the Nasdaq Global Market ("Nasdaq") under its current
symbol "CRMD". The Company expects that its common stock will begin trading on
Nasdaq on February 2, 2021.
Also on January 21, 2021, the Company informed the NYSE American (the "NYSE")
that it intended to transfer its listing to Nasdaq. The Company's shares of
common stock will continue to trade on the NYSE American until the close of the
market on February 1, 2021.
A copy of the press release is filed as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated January 21, 2021
1
© Edgar Online, source Glimpses